全文获取类型
收费全文 | 4167篇 |
免费 | 306篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 148篇 |
妇产科学 | 59篇 |
基础医学 | 581篇 |
口腔科学 | 80篇 |
临床医学 | 473篇 |
内科学 | 933篇 |
皮肤病学 | 72篇 |
神经病学 | 409篇 |
特种医学 | 94篇 |
外科学 | 430篇 |
综合类 | 20篇 |
一般理论 | 2篇 |
预防医学 | 370篇 |
眼科学 | 153篇 |
药学 | 326篇 |
中国医学 | 2篇 |
肿瘤学 | 273篇 |
出版年
2023年 | 75篇 |
2022年 | 60篇 |
2021年 | 94篇 |
2020年 | 110篇 |
2019年 | 137篇 |
2018年 | 108篇 |
2017年 | 121篇 |
2016年 | 114篇 |
2015年 | 130篇 |
2014年 | 159篇 |
2013年 | 243篇 |
2012年 | 318篇 |
2011年 | 332篇 |
2010年 | 155篇 |
2009年 | 195篇 |
2008年 | 251篇 |
2007年 | 249篇 |
2006年 | 210篇 |
2005年 | 178篇 |
2004年 | 169篇 |
2003年 | 182篇 |
2002年 | 128篇 |
2001年 | 49篇 |
2000年 | 58篇 |
1999年 | 35篇 |
1998年 | 42篇 |
1997年 | 31篇 |
1996年 | 23篇 |
1995年 | 33篇 |
1994年 | 21篇 |
1993年 | 14篇 |
1992年 | 32篇 |
1991年 | 25篇 |
1990年 | 21篇 |
1989年 | 21篇 |
1988年 | 22篇 |
1987年 | 20篇 |
1986年 | 19篇 |
1985年 | 17篇 |
1984年 | 22篇 |
1983年 | 11篇 |
1982年 | 25篇 |
1981年 | 14篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1974年 | 19篇 |
1972年 | 11篇 |
1970年 | 8篇 |
1968年 | 13篇 |
1967年 | 8篇 |
排序方式: 共有4478条查询结果,搜索用时 31 毫秒
51.
52.
53.
Halfdan S?rbye Bengt Glimelius Ake Berglund Tone Fokstuen Kjell Magne Tveit Morten Braendengen Dagfinn ?greid Olav Dahl 《Journal of clinical oncology》2004,22(1):31-38
PURPOSE: This Nordic multicenter phase II study evaluated the efficacy and safety of oxaliplatin combined with the Nordic bolus schedule of fluorouracil (FU) and folinic acid (FA) as first-line treatment in metastatic colorectal cancer. PATIENTS AND METHODS: Eighty-five patients were treated with oxaliplatin 85 mg/m(2) as a 2-hour infusion on day 1, followed by a 3-minute bolus injection with FU 500 mg/m(2) and, 30 minutes later, by a bolus injection with FA 60 mg/m(2) every second week. The same doses of FU and FA were also given on day 2. RESULTS: Fifty-one of 82 assessable patients achieved a complete (n = 4) or partial (n = 47) response, leading to a response rate of 62% (95% CI, 52% to 72%). Nineteen patients showed stable disease, and 12 patients had progressive disease. Thirty-eight of the 51 responses were radiologically confirmed 8 weeks later (confirmed response rate, 46%; 95% CI, 36% to 58%). The estimated median time to progression was 7.0 months (95% CI, 6.3 to 7.7 months), and the median overall survival was 16.1 months (95% CI, 12.7 to 19.6 months) in the intent-to-treat population. Neutropenia was the main adverse event, with grade 3 to 4 toxicity in 58% of patients. Febrile neutropenia developed in seven patients. Nonhematologic toxicity consisted mainly of neuropathy (grade 3 in 11 patients and grade 2 in another 27 patients). CONCLUSION: Oxaliplatin combined with the bolus Nordic schedule of FU+FA (Nordic FLOX) is a well-tolerated, effective, and feasible bolus schedule as first-line treatment of metastatic colorectal cancer that yields comparable results compared with more complex schedules. 相似文献
54.
55.
CONTEXT: Population-based data on cancers associated with acquired immunodeficiency syndrome (AIDS) in children are lacking. OBJECTIVE: To determine risk of pediatric AIDS-associated cancers. DESIGN, SETTING, AND PARTICIPANTS: Using records from 11 locations in the United States for varying periods between 1978 and 1996, we linked data for children aged 14 years and younger at AIDS diagnosis to local cancer registry data. MAIN OUTCOME MEASURES: Cancer frequency and, in the 2-year post-AIDS onset period, cancer incidence and relative risk (RR; measured as standardized incidence ratio), by cancer type. RESULTS: Among 4954 children with AIDS, 124 (2.5%) were identified as having cancer before, at, or after AIDS onset, including 100 cases of non-Hodgkin lymphoma (NHL), 8 of Kaposi sarcoma (KS), 4 of leiomyosarcoma, and 2 of Hodgkin disease; there were 10 other or unspecified cancers. Expected numbers for all cancers identified in the study sample, based on population rates (using area-specific registry data), were less than 1. In the first 2 years after AIDS diagnosis (5485 person-years), NHL incidence was 510 per 100,000 person-years (RR, 651; 95% confidence interval [CI], 432-941). Median time for developing NHL after AIDS diagnosis was 14 months (range, 3-107 months). The most common type of NHL was Burkitt lymphoma. However, the risk of primary brain lymphoma (91 per 100,000 person-years) was especially high (RR, 7143; 95% CI, 2321-16,692), and 4 cases were diagnosed more than 2 years (range, 37-98 months) after AIDS onset. Leiomyosarcomas also tended to occur several years after AIDS onset, with 3 of the 4 cases occurring 33 to 76 months after AIDS diagnosis, whereas KS was reported only at or within 2 years of AIDS diagnosis. Hodgkin disease risk was also significantly increased (RR, 62; 95% CI, 2-342). CONCLUSIONS: The spectrum of AIDS-associated pediatric cancers resembled that seen in adults, with the addition of leiomyosarcoma. Both primary brain lymphomas and leiomyosarcomas tended to occur in children surviving several years after AIDS onset. Because the expected numbers of these cancers in this population were less than 1 and because of the small numbers of some types of observed cancers, the RR estimates are imprecise and caution is warranted in their interpretation. JAMA. 2000;284:205-209 相似文献
56.
目的:探讨不同HIV蛋白酶抑制剂对胰岛beta-细胞功能的影响。方珐:体外观察不同浓度ritonavir或amprenavir干预48h对鼠胰岛素瘤INS-1细胞葡萄糖刺激的胰岛素释放速率的影响,胰岛素测定采用ELISA法,并用细胞内DNA含量标准化。用苔盘蓝染色细胞计数、MTT试验评估ritonavir或amprenavir对INS-1细胞活力的影响。结果:Ritonavir治疗可以显著降低基础胰岛素分泌速率及葡萄糖刺激的胰岛素释放速率,并呈剂量依赖关系(r分别为-0.861,-0.839,均P〈0.01)。10μmol/L ritonavir分别降低基础胰岛素分泌和葡萄糖刺激的胰岛素释放达46%和47%。Amprenavir对胰岛素释放功能没有影响。结论:不同HIV蛋白酶抑制剂对胰岛beta-细胞功能的影响不同。 相似文献
57.
The disturbance caused by various short propagation delays to the perception of external sounds and own voice for a non-occluding hearing aid was investigated. Ten normal-hearing and 10 mildly hearing-impaired individuals listened to external sounds and their own voice while wearing non-occluding devices providing 10dB of linear gain. Participants rated the disturbance caused by delays of 2, 4 and 10ms to music, running speech, and their own voices. The results indicated greater disturbance for the longest delay for both subject groups when judging own voice, with the ratings of the hearing-impaired participants being lowest. Normal-hearing participants also judged the 10-ms delay as more disturbing for the external sounds. Owing to the listening conditions with constant gain from 800Hz and above, the results apply directly only to this experiment. Disturbance ratings for all delays were low, which suggests that any of those tested would be acceptable for this application. 相似文献
58.
Steffen Eickhardt Peter Braendstrup Erik Clasen‐Linde Karl E. Jensen Morten Alhede Thomas Bjarnsholt Niels Høiby Lars Vindeløv Claus Moser 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2013,121(5):456-459
Post‐transplant infections in allogeneic haematopoietic cell transplant (allo‐HCT) recipients often have severe consequences. This is especially the case when dealing with zygomycete infections where the result is often fatal. A major problem when dealing with zygomycete infections is the need for an accurate and fast diagnosis as the phylum is highly resistant towards the conventional antifungals. We herein describe a non‐fatal case of Lichtheimia corymbifera infection in an allo‐HCT recipient. 相似文献
59.
60.
Morten Tulstrup Thomas L. Frandsen Jonas Abrahamsson Bendik Lund Kim Vettenranta Olafur Gisli Jonsson Hanne Vibeke Hansen Marquart Birgitte Klug Albertsen Mats Heyman Kjeld Schmiegelow On behalf of the Nordic Society of Paediatric Haematology Oncology 《European journal of haematology》2018,100(1):53-60